Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure

References

1. University of QueenslandBurkholderia pseudomallei strain: TSV-377 | isolate (ID 1032635) National Center for Biotechnology Information 2023 https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1032635 accessed 13 February 2024
   [Google Scholar]
2. Gassiep I, Armstrong M, Norton R. Human melioidosis. Clin Microbiol Rev 2020; 33:e00006-19 [View Article] [PubMed]
   [Google Scholar]
3. Limmathurotsakul D, Golding N, Dance DAB, Messina JP, Pigott DM et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016; 1:15008 [View Article] [PubMed]
   [Google Scholar]
4. Sullivan RP, Marshall CS, Anstey NM, Ward L, Currie BJ. 2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift. PLoS Negl Trop Dis 2020; 14:e0008659 [View Article] [PubMed]
   [Google Scholar]
5. Smith MD, Wuthiekanun V, Walsh AL, White NJ. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei. J Antimicrob Chemother 1996; 37:611–615 [View Article] [PubMed]
   [Google Scholar]
6. Dance DA, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989; 24:295–309 [View Article] [PubMed]
   [Google Scholar]
7. Smith MD, Wuthiekanun V, Walsh AL, White NJ. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies. J Antimicrob Chemother 1994; 33:145–149 [View Article] [PubMed]
   [Google Scholar]
8. Novak RT, Glass MB, Gee JE, Gal D, Mayo MJ et al. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol 2006; 44:85–90 [View Article] [PubMed]
   [Google Scholar]
9. CLSI M45 Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, 3rd edition Clinical and Laboratory Standards Institute; 2015
   [Google Scholar]
10. Somprasong N, Hall CM, Webb JR, Sahl JW, Wagner DM et al. Burkholderia ubonensis meropenem resistance: insights into distinct properties of class A β-lactamases in Burkholderia cepacia complex and Burkholderia pseudomallei complex bacteria. mBio 2020; 11:e00592-20 [View Article] [PubMed]
    [Google Scholar]
11. Price EP, Sarovich DS, Webb JR, Hall CM, Jaramillo SA et al. Phylogeographic, genomic, and meropenem susceptibility analysis of Burkholderia ubonensis. PLoS Negl Trop Dis 2017; 11:e0005928 [View Article] [PubMed]
    [Google Scholar]
12. Madden DE, Webb JR, Steinig EJ, Currie BJ, Price EP et al. Taking the next-gen step: comprehensive antimicrobial resistance detection from Burkholderia pseudomallei. EBioMedicine 2021; 63:103152 [View Article] [PubMed]
    [Google Scholar]
13. Fen SHY, Tandhavanant S, Phunpang R, Ekchariyawat P, Saiprom N et al. Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates. Antimicrob Agents Chemother 2023; 95:e02230-20 [View Article] [PubMed]
    [Google Scholar]
14. Crowe A, McMahon N, Currie BJ, Baird RW. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Int J Antimicrob Agents 2014; 44:160–162 [View Article] [PubMed]
    [Google Scholar]
15. Bugrysheva JV, Sue D, Hakovirta J, Loparev VN, Knipe K et al. Finished annotated genome sequence of Burkholderia pseudomallei strain BP1651, a multidrug-resistant clinical isolate. Genome Announc 2015; 3:e01427-15 [View Article] [PubMed]
    [Google Scholar]
16. Nuryastuti T, Umaroh N, Asdie RH, Sari IP, Musthafa A. Pan-drug-resistant and biofilm-producing strain of Burkholderia pseudomallei: first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia. Int Med Case Rep J 2018; 11:319–323 [View Article] [PubMed]
    [Google Scholar]
17. Sarovich DS, Webb JR, Pitman MC, Viberg LT, Mayo M et al. Raising the stakes: loss of efflux pump regulation decreases meropenem susceptibility in Burkholderia pseudomallei. Clin Infect Dis 2018; 67:243–250 [View Article] [PubMed]
    [Google Scholar]